Tumor inhibition and effects on host survival time by rutheniumIII and rhodiumIII complexes with dimethylsulphoxide ligands.
Pacor
S
S
Istituto di Farmacologia, Facoltà di Farmacia, Università di Trieste.
Sava
G
G
Mestroni
G
G
Alessio
E
E
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D009942:Organometallic Compounds / Q000627:therapeutic use*; D012238:Rhodium / Q000627:therapeutic use*; D012428:Ruthenium / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009942:Organometallic Compounds; D012428:Ruthenium; D012238:Rhodium